Subscribe to Breaking News emails

You have successfully subscribed to the Breaking News email.

Subscribe today to be the first to to know about breaking news and special reports.

Treatment against peanut allergy protected kids in new study

Flour sprinkled over food helped sensitize children to nuts, the company said

 / Updated  / Source: Associated Press
Creamy peanut butter and peanuts.Hera Food / Alamy

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.

The first treatment to help prevent serious allergic reactions to peanuts may be on the way. A company said Tuesday that its daily capsules of peanut flour helped sensitize children to nuts in a major study.

Millions of children have peanut allergies, and some may have life-threatening reactions if accidentally exposed to them. Doctors have been testing daily doses of peanut flour, contained in a capsule and sprinkled over food, as a way to prevent that.

California-based Aimmune Therapeutics said 67 percent of kids who had its treatment were able to tolerate the equivalent of roughly two peanuts at the end of the study, compared to only 4 percent of others given a dummy powder.

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.

The study involved nearly 500 kids ages 4 to 17 with severe peanut allergies. They were given either capsules of peanut flour or a dummy powder in gradually increasing amounts for six months, then continued on that final level for another six months. Neither the participants nor their doctors knew who was getting what until the study ended.

About 20 percent of kids getting the peanut powder dropped out of the study, 12 percent due to reactions or other problems.

The results have not yet been reviewed by independent experts, but will be presented at a medical meeting next month.

The company plans to file for U.S. Food and Drug Administration approval for the treatment by the end of this year, and for approval in Europe early next year.

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.
MORE FROM news

Have feedback?

How likely are you to recommend nbcnews.com to a friend or colleague?

0 = Very unlikely
10 = Very likely
Please select answer

Is your feedback about:

Please select answer

Leave your email if you’d like us to respond. (Optional)

Please enter a valid email address

Thank you!

Your feedback has been sent out. Please enjoy more of our content.

We appreciate your help making nbcnews.com a better place.